On August 26, Oklo Inc. fell 5.17% in regular trading, trading at $41.95 per share, with turnover of $374 million. The decline was driven by multiple analysts cutting their earnings forecasts following Q2 results, compounded by concentrated insider selling from top executives.

On the news front, CEO Jacob DeWitte and COO Caroline Cochran each filed Form 144 plans to sell 400,000 shares of Class A common stock, totaling approximately $31 million in combined value. Meanwhile, several analysts revised their profit outlooks downward after Q2 earnings showed a loss of $0.28 per diluted share, significantly wider than the consensus estimate of a $0.16 loss, representing a 75% miss. Revenue of $1.21 million marked the company's first quarterly revenue but failed to offset concerns over accelerating losses.

Although Oklo's small modular reactor achieved criticality status and received multiple DOE approvals, the combination of widening short-term losses and sustained executive share disposals continued to dominate market sentiment, reversing gains from earlier in the session when nuclear power stocks broadly advanced.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)